论文部分内容阅读
目的探究在老年人压疮治疗的过程中,使用重组人表皮生长因子联合微波理疗治疗的疗效。方法选取朝阳区人民医院2013年8月~2016年5月收治的老年人压疮患者80例,分为对照组和观察组,各40例。对照组采用常规方法治疗,观察组采用重组人表皮生长因子联合微波理疗治疗,对比两组患者疗效。结果针对性比较两组患者的创面愈合时间发现,观察组患者用时(7.12±1.06)天,明显短于对照组的(9.78±1.23)天,差异有统计学意义(P<0.05)。针对性比较两组患者的治疗有效率发现,观察组患者明显较高,差异有统计学意义(P<0.05)。两组共80例患者均未出现明显的不良反应。结论重组人表皮生长因子联合微波理疗治疗老年人压疮的临床应用效果良好,能够快速促进患者的创面愈合,同时提高患者的治疗有效率,因此值得临床借鉴。
Objective To explore the effect of using recombinant human epidermal growth factor combined with microwave therapy in the treatment of pressure ulcer in the elderly. Methods Eighty elderly patients with pressure ulcers admitted from August 2013 to May 2016 in Chaoyang District People’s Hospital were divided into control group and observation group, 40 cases in each group. The control group was treated by conventional method. The observation group was treated with recombinant human epidermal growth factor combined with microwave therapy. The curative effect was compared between the two groups. Results Compared the wound healing time of the two groups, the patients in the observation group were significantly shorter than those in the control group (7.12 ± 1.06 days vs 9.78 ± 1.23 days, P <0.05). Targeted comparison of two groups of patients found that the treatment group was significantly higher, the difference was statistically significant (P <0.05). A total of 80 patients in both groups showed no significant adverse reactions. Conclusion The clinical application of recombinant human epidermal growth factor combined with microwave therapy for the treatment of pressure ulcers in the elderly is effective and can rapidly promote the wound healing of patients and improve the treatment efficiency of patients. Therefore, it is worthy of clinical reference.